Report
Nikolaas Faes

Canopy Growth: C-day 17 October 2018

Canopy Growth: (BUY, Fair Value C$51 (+12%))
C-day 17 October 2018
Yesterday the Canadian government decided that from 17 October 2018 onwards, selling cannabis for recreational purposes would be legal. That is 17 weeks from now and beyond the previous indicated 8-12 weeks’ time frame. However, giving more time to the provinces and territories (some big provinces did indicate they would struggle to have their sales system ready), will allow for a smooth implementation of the law across the country. In provinces that are not ready on 17 October LPs will be allow to sell on-line directly to customers.
Underlying
Canopy Growth Corporation

Canopy Growth is a licensed producer of medical marijuana in Canada. The principal activities of Co. are the production and sale of marijuana out of its facility in Smiths Falls, Ontario as regulated by the "Marijuana for Medical Purposes Regulations".

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Nikolaas Faes

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch